Wearable battery-free chip-less patch for bioimpedance measurement of cutaneous lesions

Melanoma is an invasive type of skin cancer that may metastasize and cause death. Early identification and timely management of melanoma significantly increase the chance of successful treatment and reduce the mortality rate. Visual inspection of pigmented lesions is not objective, often necessitating additional diagnostic procedures such as dermoscopy, reflectance confocal microscopy and biopsy. Here, we developed a wireless, battery-free, chip-less patch that non-invasively measures bio-impedance of lesions and suspicious parts of skin to melanoma as a complementary, nonvisual, wearable device. The patch, in conjunction with personal electronics, can detect abnormal bioimpedances that are associated with the risk of melanoma and alert the need for medical consultation in the early stage of development. Our analytical and experimental results as well as a pilot human subject study showed that the wearable patch identified the difference in bioimpedance of pigmented lesions and healthy tissues on skin for early assessment of lesions.

Authors

Institutions

Publication Details

Journal
npj Biomedical Innovations.
Published
2025-10-03
DOI
https://doi.org/10.1038/s44385-025-00037-7
Primary Topic
Microfluidic and Bio-sensing Technologies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Wearable battery-free chip-less patch for bioimpedance measurement of cutaneous lesions

Enosh Lim, Ellaine Ray, Mohammad J. Moghimi, Mansour Tahernezhadi et al.
npj Biomedical Innovations.
Microfluidic and Bio-sensing Technologies
article

Wearable battery-free chip-less patch for bioimpedance measurement of cutaneous lesions

Enosh Lim, Ellaine Ray, Mohammad J. Moghimi, Mansour Tahernezhadi, Hina Imtiaz
article en

Abstract

Melanoma is an invasive type of skin cancer that may metastasize and cause death. Early identification and timely management of melanoma significantly increase the chance of successful treatment and reduce the mortality rate. Visual inspection of pigmented lesions is not objective, often necessitating additional diagnostic procedures such as dermoscopy, reflectance confocal microscopy and biopsy. Here, we developed a wireless, battery-free, chip-less patch that non-invasively measures bio-impedance of lesions and suspicious parts of skin to melanoma as a complementary, nonvisual, wearable device. The patch, in conjunction with personal electronics, can detect abnormal bioimpedances that are associated with the risk of melanoma and alert the need for medical consultation in the early stage of development. Our analytical and experimental results as well as a pilot human subject study showed that the wearable patch identified the difference in bioimpedance of pigmented lesions and healthy tissues on skin for early assessment of lesions.

npj Biomedical Innovations.Vol. 2(1)
Northern Illinois University (US), Rowan University (US), Wake Forest University (US)
Northern Illinois University, Comprehensive Cancer Center at Wake Forest Baptist Medical Center, Rowan University, National Institutes of Health, National Institute on Deafness and Other Communication Disorders
Openalex Percentile: Top 74%
Microfluidic and Bio-sensing Technologies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Wearable battery-free chip-less patch for bioimpedance measurement of cutaneous lesions — Enosh Lim, Ellaine Ray, et al. · npj Biomedical Innovations. (2025) | TGRS Research Map | TGRS